Data from EMC - Curated by Toby Galbraith - Last updated 28 July 2016

Indication(s)

Hormone replacement therapy (HRT) for oestrogen deficiency symptoms in perimenopausal and postmenopausal women.

Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.

 

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

COPD

View highlights from recent congresses presented in new expert videos with leading physicians

Visit COPD

Obesity

Learn about the complex factors influencing development of obesity

Visit Obesity

More information

Category Value
Orphan designation No
Type POM
Marketing authorisation holder Meda Pharmaceuticals Ltd

Related Content